Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
On 11 June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight loss
Insurance providers potentially covering semaglutide encompass United Healthcare, Cigna, and Blue Cross Blue Shield
The Precision Peptide Genetic Test (available for $298) can identify whether your genetic profile predisposes you to slower GI transit, helping your provider tailor management strategies proactively
Losing weight can help lower androgen levels and may lead to more regular menstrual cycles
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
